Skip to content

Medical-device intelligence

Medical Analysis Systems, Inc.: FDA clearances and recalls

Research Medical Analysis Systems, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

107 clearance records and 0 recall records in the covered releases, across 1 source company names and 38 product codes. Dated history runs from Feb 7, 1978 to Nov 5, 2004.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

107 matching records
Device / recordCompany in FDA recordSourceSource date
CARDIOIMMUNE CARDIAC MARKER CONTROL LEVELS 1,2, AND 3K984277 · JJTMedical Analysis Systems, Inc.510(k)Dec 9, 1998FDA decision date
OPIATES 2000 LIQUID OPIATES DRUGS OF ABUSE CONTROL LEVELS G2 AND G3K983127 · DIFMedical Analysis Systems, Inc.510(k)Sep 14, 1998FDA decision date
URICHEMTRAK LIQUID ASSAYED CONTROL LEVELS 1 AND 2K981933 · JJWMedical Analysis Systems, Inc.510(k)Jun 29, 1998FDA decision date
OPIATES 2000 LIQUID OPIATES DRUGS OF ABUSE CONTROL LEVELS 2 AND 3K982024 · DIFMedical Analysis Systems, Inc.510(k)Jun 29, 1998FDA decision date
CHEMTRAK PLATINUM COMPREHENSIVE LIQUID ASSAYED CHEMISTRY AND TDM CONTROL LEVEL 1, MODEL AP11001, LEVEL 2, MODEL AP22002K980514 · JJYMedical Analysis Systems, Inc.510(k)Mar 4, 1998FDA decision date
MAS LIQUID URINALYSIS CONTROL LEVEL 1, LEVEL 2 AND LEVEL 3K973451 · JJWMedical Analysis Systems, Inc.510(k)Sep 29, 1997FDA decision date
CARDIOISOZYME, CK/LD ISOENZYME CONTROLK970856 · JJTMedical Analysis Systems, Inc.510(k)Apr 8, 1997FDA decision date
DOA-XSE, LIQUID DRUGS OF ABUSE CONTROL LEVELS 2,3, AND 4 (SDOA- 202,303,404)K971058 · DIFMedical Analysis Systems, Inc.510(k)Apr 8, 1997FDA decision date
CARDIOIMMUNE CARDIAC MARKER CONTROL, LEVELS 1,2 AND 3K970976 · JJYMedical Analysis Systems, Inc.510(k)Apr 2, 1997FDA decision date
IMMUNOLOGY CONTROLK960824 · JJYMedical Analysis Systems, Inc.510(k)Apr 23, 1996FDA decision date
LIPID CONTROLK960862 · JJYMedical Analysis Systems, Inc.510(k)Apr 3, 1996FDA decision date
MAS LIQUID URINALYSIS CONTROLK954323 · JJYMedical Analysis Systems, Inc.510(k)Nov 9, 1995FDA decision date
TRI-POINT LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROLK954322 · DIFMedical Analysis Systems, Inc.510(k)Oct 11, 1995FDA decision date
CSF LIQUID CEREBROSPINAL FLUID CONTROLK952877 · JJYMedical Analysis Systems, Inc.510(k)Aug 24, 1995FDA decision date
MAS LIQUID ASSAYED ALCOHOL/AMMONIA CONTROL LEVEL 1 AND 2K951057 · DCKMedical Analysis Systems, Inc.510(k)Apr 20, 1995FDA decision date
LIQUID ASSAYED TUMOR MARKER CONTROL LEVEL 1, LEVEL 2, LEVEL 3K944525 · JJYMedical Analysis Systems, Inc.510(k)Mar 21, 1995FDA decision date
TRAK LIQUID CEREBROSPINAL FLUID CONTROL LEVELS 1 & 2K941328 · JJYMedical Analysis Systems, Inc.510(k)Aug 18, 1994FDA decision date
DOA LIQUID DRUGS OF ABUSE CONTROLS LEVLS 2,3,& 4,G2,G3,& G4K940433 · DIFMedical Analysis Systems, Inc.510(k)Jul 20, 1994FDA decision date
CHEMTRAK LIQUID UNASSAYED THERAPEUTIC DRUG CONTROLSK936166 · DIFMedical Analysis Systems, Inc.510(k)Jul 13, 1994FDA decision date
DOA LIQUID DRUGS OF ABUSE CONTROLSK934498 · DIFMedical Analysis Systems, Inc.510(k)Jul 6, 1994FDA decision date
CEDIA DAU CONTROLSK934650 · DIFMedical Analysis Systems, Inc.510(k)Apr 26, 1994FDA decision date
MAS LIQUID URINALYSIS CONTROLK935062 · JJWMedical Analysis Systems, Inc.510(k)Jan 27, 1994FDA decision date
TRI-POINT BRAND LIQUIMMUNE IMMUNOASSAY CONTR 1,2 & 3K934056 · JJYMedical Analysis Systems, Inc.510(k)Oct 18, 1993FDA decision date
TRI-POINT LIQUIMMUNE IMMUONASSAY CONTROL, L-1,2,3K931366 · JJYMedical Analysis Systems, Inc.510(k)Jul 28, 1993FDA decision date
REFLAB SYSTEM PACK LIQUID CO2 REAGENTK926320 · CHSMedical Analysis Systems, Inc.510(k)Feb 3, 1993FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗